Cerus Corporation - Common Stock - Nakit Akışı (NASDAQ:CERS)

Financials

İşletme faaliyetlerinden elde edilen nakit -40.74 M-33.92 M-25.61 M-43.17 M11.36 M4.84 M 2.63 M Yatırım faaliyetlerinden elde edilen nakit -49.56 M12.69 M8.46 M8.62 M-8.13 M-6.17 M 4.88 M Finansman faaliyetlerinden elde edilen nakit 91.78 M34.29 M4.19 M10.67 M4.96 M231 K 352 K Serbest nakit akışı -40.74 M-33.92 M-25.61 M-43.17 M11.36 M1.11 M -1.22 M

Cerus Corporation - Common Stock

Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.

CERS

Financials

Cerus Corporation - Common Stock

Haberler

Cerus Corporation: Strong Q1 Results Validate The Turnaround Thesis (NASDAQ:CERS)

Top 3 Health Care Stocks That May Collapse This Month - Apellis Pharmaceuticals (NASDAQ:APLS), Avanos Med

Cerus Corporation (CERS) Q1 2026 Earnings Call Transcript

Cerus, Fransız kan servisi ile dört yıllık tedarik anlaşması imzaladı

Jensen, Cerus Corp hukuk müdürü, 187 bin dolarlık hisse sattı

Jensen, Cerus Corp chief legal officer, sells $187k in stock

Cerus Corp CFO 211 bin dolarlık hisse sattı

Cerus Corp CEO’su Greenman 742 bin dolarlık hisse sattı

Cerus Corp COO Jayaraman 273 bin dolarlık hisse sattı

Cerus Corp: Tıbbi direktör Benjamin 168 bin dolarlık hisse sattı

Cerus Corp COO Jayaraman sells $273k in shares

Cerus Corp CEO Greenman sells $742k in shares